Association between age, deprivation and specific comorbid conditions and the receipt of major surgery in patients with non-small cell lung cancer in England: A population-based study

Lung Cancer

Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study

Lancet Respir Med.

Lin CC, Shih JY, Yu CJ, Ho CC, Liao WY, Lee JH, Tsai TH, Su KY, Hsieh MS, Chang YL, Bai YY, Huang DD, Thress KS, Yang JC

RECOMMENDED

Lung Cancer

Definitive treatment patterns and survival in stage II non-small cell lung cancer

doi: 10.1016/j.lungcan.

RECOMMENDED

Lung Cancer

Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study

★ 1 Recommended by Prof. Dr Stephan Bodis, Faculty Member

★ 2 Recommended by Alexander Meisel, Faculty Member

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

Lancet Oncol.

Hui R, Özgüroğlu M, Villegas A, Daniel D, Vicente D, Murakami S, Yokoi T, Chiappori A, Lee KH, de Wit M, Cho BC, Gray JE, Rydén A, Viviers L, Poole L, Zhang Y, Dennis PA, Antonia SJ

doi: 10.1016/S1470-2045(19)30519-4.

Lung Cancer

The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States

Clin Lung Cancer.

Cushman TR, Jones B, Akhavan D, Rusthoven CG, Verma V, Salgia R, Sedrak M, Massarelli E, Welsh JW, Amini A

doi: 10.1016/j.cllc.2020.09.004.

RECOMMENDED

Further Publications

Risk factors for non-cancer death after surgery in patients with stage I non-small-cell lung cancer

★ 1 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Eur J Cardiothorac Surg

Kanzaki R, Nagoya A, Kanou T, Ose N, Funaki S, Minami M, Okamoto Y, Tabuchi H, Hoshino T, Tajima T, Fujii M, Ohno Y, Shintani Y

doi: 10.1093/ejcts/ezaa333

RECOMMENDED

Lung Cancer

Association of baseline symptom burden with efficacy outcomes: Exploratory analysis from the randomized phase III REVEL study in advanced non-small-cell lung cancer

Lung Cancer.

Pérol M, Winfree KB, Cuyun Carter G, Lin Cui Z, Bowman L, Garon EB

doi: 10.1016/j.lungcan.2019.03.001.

RECOMMENDED

Lung Cancer

A multicenter study of thromboembolic events among patients diagnosed with ROS1-rearranged non-small cell lung cancer

★ 1 Recommended by Dr Martin Frey, Faculty Member

Lung Cancer.

Alexander M, Pavlakis N, John T, O'Connell R, Kao S, Hughes BGM, Lee A, Hayes SA, Howell VM, Clarke SJ, Millward M, Burbury K, Solomon B, Itchins M

doi: 10.1016/j.lungcan.2020.01.017.

RECOMMENDED

Lung Cancer

Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non-small-cell Lung Cancer (NSCLC): An Italian, Multicenter, Retrospective Study

Clin Lung Cancer.

Luciani A, Marra A, Toschi L, Cortinovis D, Fava S, Filipazzi V, Tuzi A, Cerea G, Rossi S, Perfetti V, Rossi A, Giannetta L, Sala L, Finocchiaro G, Pizzutilo EG, Carelli S, Agustoni F, Cergnul M, Zonato S, Siena S, Bidoli P, Ferrari D

doi: 10.1016/j.cllc.2020.05.004.

RECOMMENDED

Lung Cancer

Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and Zug

Lung Cancer.

Stahel RA, Curioni-Fontecedro A, Rohrmann S, Dafni U, Sandner U, Opitz I, Andratschke N, Franzen D, Dimopoulou G, Matthes KL, Kohler M, Guckenberger M, Weder W

doi: 10.1016/j.lungcan.2020.05.037.

Related content

Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study

Definitive treatment patterns and survival in stage II non-small cell lung cancer

Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study

The Effects of Time to Treatment Initiation for Patients With Non-small-cell Lung Cancer in the United States

Risk factors for non-cancer death after surgery in patients with stage I non-small-cell lung cancer

Association of baseline symptom burden with efficacy outcomes: Exploratory analysis from the randomized phase III REVEL study in advanced non-small-cell lung cancer

A multicenter study of thromboembolic events among patients diagnosed with ROS1-rearranged non-small cell lung cancer

Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non-small-cell Lung Cancer (NSCLC): An Italian, Multicenter, Retrospective Study

Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and Zug